GlassScriptPhysician profile
Jason Michael Levy
NPI 1861435414
$7,181.66
in general payments reported to CMS, 2019-2025
19 companies · $1,769 in 2025
The $1,769 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $679 · 2020: $363 · 2021: $1,800 · 2022: $446 · 2023: $340 · 2024: $1,784 · 2025: $1,769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,043 · Food and Beverage: $1,683 · Education: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,043.05 |
| Food and Beverage | $1,682.91 |
| Education | $167.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,859.61 | 2019-2025 | Easyfuse, Citrefix, Actishield |
| Endo USA, INC. | $2,597.54 | 2024-2025 | |
| Orthofix Medical, INC. | $392.81 | 2019-2023 | Physio-Stim |
| Wright Medical Technology, INC. | $310.22 | 2019-2020 | |
| Organogenesis INC. | $300.47 | 2019-2025 | Affinity, Apligraf |
| Medtronic Vascular, INC. | $277.60 | 2019 | |
| Mvp Orthopedics INC | $131.27 | 2022 | |
| Kerecis Limited | $69.25 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Globus Medical, INC. | $37.56 | 2024 | Harvest |
| Bioventus LLC | $36.62 | 2021 | |
| Alfasigma USA, INC. | $35.24 | 2021 | |
| Zyla Life Sciences, INC. | $29.48 | 2019 | |
| Linvatec Corporation | $25.95 | 2025 | Fracture and Correction Colag 2, Biobrace 23mm |
| Sandoz INC. | $18.64 | 2019 | |
| Acumed LLC | $16.84 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $16.61 | 2019 | |
| Merck Sharp & Dohme LLC | $13.28 | 2019 | |
| Horizon Therapeutics Plc | $12.67 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.